Jackson Square Capital
TMO icon

Jackson Square Capital’s Thermo Fisher Scientific TMO Stock Holding History

Jackson Square Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.98M Buy
4,421
+206
+5% +$122K 0.45% 46
2026
Q2 		$2.11M Sell
4,215
-322
-7% -$155K 0.29% 51
2026
Q1 		$2.23M Sell
4,537
-74
-2% -$40.2K 0.47% 49
2025
Q4 		$2.67M Buy
4,611
+44
+1% +$24.9K 0.53% 46
2025
Q3 		$2.22M Sell
4,567
-656
-13% -$305K 0.48% 47
2025
Q2 		$2.12M Sell
5,223
-35
-0.7% -$14.6K 0.47% 51
2025
Q1 		$2.62M Sell
5,258
-685
-12% -$371K 0.85% 29
2024
Q4 		$3.09M Sell
5,943
-4,367
-42% -$2.4M 0.75% 34
2024
Q3 		$6.38M Buy
10,310
+4,268
+71% +$2.53M 1.58% 18
2024
Q2 		$3.34M Sell
6,042
-39
-0.6% -$22.3K 0.82% 34
2024
Q1 		$3.53M Buy
6,081
+43
+0.7% +$24.1K 0.91% 36
2023
Q4 		$3.2M Sell
6,038
-4,394
-42% -$2.13M 1.03% 29
2023
Q3 		$5.28M Buy
10,432
+222
+2% +$118K 2.12% 16
2023
Q2 		$5.33M Sell
10,210
-1,137
-10% -$614K 2.14% 14
2023
Q1 		$6.54M Sell
11,347
-22
-0.2% -$12.4K 2.93% 6
2022
Q4 		$6.26M Sell
11,369
-326
-3% -$173K 2.95% 5
2022
Q3 		$5.93M Sell
11,695
-12
-0.1% -$6.72K 2.89% 6
2022
Q2 		$6.36M Buy
11,707
+170
+1% +$93.6K 2.69% 6
2022
Q1 		$6.81M Buy
11,537
+188
+2% +$108K 2.13% 11
2021
Q4 		$7.57M Buy
11,349
+239
+2% +$149K 2.18% 9
2021
Q3 		$6.35M Sell
11,110
-2
-0% -$1.1K 2.06% 8
2021
Q2 		$5.61M Sell
11,112
-207
-2% -$97.7K 1.8% 12
2021
Q1 		$5.17M Sell
11,319
-336
-3% -$160K 1.97% 9
2020
Q4 		$5.43M Buy
11,655
+271
+2% +$127K 2.09% 11
2020
Q3 		$5.03M Buy
11,384
+1,711
+18% +$707K 2.21% 7
2020
Q2 		$3.5M Buy
9,673
+433
+5% +$145K 1.77% 19
2020
Q1 		$2.62M Sell
9,240
-1,260
-12% -$397K 2.04% 14
2019
Q4 		$3.41M Buy
+10,500
New +$3.18M 1.97% 10

Other funds holding TMO

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Sarasin & Partners
Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return
James Hambro & Partners
James Hambro & Partners London, United Kingdom $2.87B AUM 19.92% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Egerton Capital (UK)
Egerton Capital (UK) London, United Kingdom $9.8B AUM 22.76% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Perpetual Ltd
Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return

Jackson Square Capital's TMO Position: Q3 2026 in Review

Jackson Square Capital increased its Thermo Fisher Scientific (TMO) stake by 4.9% in Q3 2026, buying an estimated $122K and bringing the position to 4,421 shares worth $2.98M. The position accounts for 0.45% of the portfolio, ranked #46.

Jackson Square Capital first reported a position in TMO in Q4 2019 and has held it in 28 quarters since. The position peaked at $7.57M in Q4 2021. 598 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Jackson Square Capital held 4,421 shares of Thermo Fisher Scientific worth $2.98M as of Q3 2026.
  • Jackson Square Capital bought 206 Thermo Fisher Scientific shares in Q3 2026, an estimated $122K.
  • Thermo Fisher Scientific made up 0.45% of Jackson Square Capital's portfolio in Q3 2026, its #46 holding.
  • Jackson Square Capital first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 28 quarters since.
  • Jackson Square Capital's Thermo Fisher Scientific position peaked at $7.57M in Q4 2021.
  • 598 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Jackson Square Capital's 13F filing for Q3 2026, filed 19 Oct 2026.